Naquotinib mesylate,
Naquotinib (mesylate),
UNII-12T09LV21O,
12T09LV21O,
1448237-05-5,
Naquotinib mesylate (USAN),
Naquotinib mesylate [USAN],
ASP8273 mesilate,
ASP-8273 mesilate,
Naquotinib mesilate (JAN),
CHEMBL3707350,
SCHEMBL18687011,
AKOS032944997,
CS-5468,
HY-19803,
D10886,
2-Pyrazinecarboxamide, 6-ethyl-3-((4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-(((3R)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl)oxy)-, methanesulfonate (1:1),
6-Ethyl-3-((4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-(((3R)-1-(1-oxoprop-2-en-1-yl)pyrrolidin-3-yl)oxy)pyrazine-2-carboxamide monomethanesulfonate,
6-Ethyl-3-(4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)anilino)-5-(((3R)-1-(prop-2-enoyl)pyrrolidin-3-yl)oxy)pyrazine-2-carboxamide monomethanesulfonate,
Naquotinib,
1448237-05-5 (mesylate),